Emma Lewisham’s Groundbreaking Probiotic Serum: A New Approach to Acne Treatment
New Zealand’s beauty brand, Emma Lewisham, has unveiled a revolutionary product – a live skin-strain probiotic serum. This innovative serum is touted as the world’s first of its kind, offering a novel approach to acne treatment that sidesteps the harsh side effects often associated with traditional methods.
The Supernatural Blemish Serum is powered by the patented Micrococcus luteus BLIS Q24. This probiotic strain, discovered on healthy human skin, is the result of two decades of meticulous research by Professor John Tagg. Each application of the serum delivers a potent dose of over 350 million live probiotic cells. These cells operate by “crowding out” the bacteria that cause blemishes and acne, as explained by the brand’s founder, Emma Lewisham.
According to clinical studies, a significant 79% of participants noted a reduction in moderate-to-severe blemishes after using the serum twice daily. The serum’s innovative dual-chamber packaging ensures the live probiotic remains stable until activation, marking a significant leap forward in microbiome-based skincare technology.
“This pioneering patented serum is crafted with 20 years of world-leading research that utilizes a unique live skin probiotic to improve the reduction of blemishes at the source,” Lewisham explains. Unlike traditional acne treatments that often cause dryness and irritation, this formulation promises to improve overall skin health while addressing acne concerns, offering hydration and reducing redness alongside blemish reduction.
For more information, visit the original source.